Huaren Pharmaceutical Co Ltd (300110): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 2,74 Renminbi Yuan | 3,66 Renminbi Yuan | 2,41 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 15,25 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.182.212.982 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.321.454,092 | 1.353.161,817 | 1.636.256,356 | 1.619.492,334 | 1.560.855,394 | 1.316.592,237 | 1.461.940,623 | 1.383.859,337 | 1.311.875,365 | 1.248.972,198 | 1.105.896,041 | 916.761,352 | 867.200,339 | 562.034,145 | 405.311,965 | 338.303,704 | 288.546,637 | 207.572,968 | 161.141,445 |
Cashflow aus operativer Geschäftstätigkeit | 390.233,529 | 322.359,889 | 305.597,473 | 217.984,061 | -578.520,393 | -10.741,42 | 309.331,524 | 254.316,028 | 211.080,36 | 181.650,11 | 18.766,954 | 65.562,085 | 39.779,06 | 99.442,783 | 59.530,885 | 77.608,752 | 38.627,597 | 57.244,298 | 7.659,899 |
▸ Operative Cashflow Marge | 29,53% | 23,82% | 18,68% | 13,46% | -37,06% | -0,82% | 21,16% | 18,38% | 16,09% | 14,54% | 1,7% | 7,15% | 4,59% | 17,69% | 14,69% | 22,94% | 13,39% | 27,58% | 4,75% |
Investitionsausgaben (CapEx) | 48.980,335 | 24.693,91 | 45.860,374 | 42.329,619 | 27.857,236 | 57.964,214 | 32.018,966 | 45.474,145 | 87.357,456 | 168.951,735 | 156.733,521 | 259.799,791 | 227.694,388 | 270.428,397 | 232.825,05 | 67.098,33 | 97.246,387 | 130.824,206 | 8.856,787 |
Cashflow aus Investitionstätigkeit | - | -37.923,861 | -97.136,548 | -143.811,467 | -458.583,5 | -237.966,918 | 5.469,674 | -55.176,924 | -95.842,891 | -168.214,763 | -156.331,789 | -228.071,618 | -285.894,751 | -353.325,596 | -222.758,11 | -66.613,306 | -96.551,003 | -140.726,982 | -8.774,255 |
Cashflow aus Finanzierungstätigkeit | - | -369.502,145 | -120.724,272 | -152.669,708 | 1.040.151,009 | 112.348,925 | -576.416,757 | 270.380,735 | 2.953,426 | -127.848,902 | 77.555,206 | 3.376,473 | 487.629,399 | 67.510,995 | -2.092,205 | 432.636,287 | 37.163,928 | 118.593,081 | 2.879,887 |
Freier Cashflow | 341.253,194 | 297.665,979 | 259.737,099 | 175.654,442 | -606.377,629 | -68.705,634 | 277.312,558 | 208.841,883 | 123.722,904 | 12.698,375 | -137.966,567 | -194.237,706 | -187.915,328 | -170.985,614 | -173.294,165 | 10.510,422 | -58.618,79 | -73.579,908 | -1.196,888 |
▸ Freie Cashflow Marge | 25,82% | 22% | 15,87% | 10,85% | -38,85% | -5,22% | 18,97% | 15,09% | 9,43% | 1,02% | -12,48% | -21,19% | -21,67% | -30,42% | -42,76% | 3,11% | -20,32% | -35,45% | -0,74% |
Ausgeschüttete Dividenden | -42.463,109 | -78.895,504 | -86.146,419 | -21.274,013 | -17.728,025 | -11.822,129 | -35.463,793 | -55.555,902 | -49.929,079 | -50.447,519 | -86.988,489 | -87.059,852 | -23.727,447 | -7.521,594 | -2.092,205 | -12.523,132 | -15.836,071 | -11.238,673 | -8.985,61 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | - | - | - | - | -20.529,887 | -21.256,304 | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.